Want to see HK:1061 full AI Analyst Report?
Total Valuation
Essex Bio-Technology has a market cap or net worth of HK$1.30B. The enterprise value is HK$1.06K.
Market CapHK$1.30B
Enterprise ValueHK$1.06K
Share Statistics
Essex Bio-Technology has 567,006,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding567,006,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Essex Bio-Technology’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.10%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)10.10%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee1.46M
Profits Per Employee334.41K
Employee Count1,240
Asset Turnover0.52
Inventory Turnover2.47
Valuation Ratios
The current PE Ratio of Essex Bio-Technology is 4.8. Essex Bio-Technology’s PEG ratio is 1.82.
PE Ratio4.8
PS Ratio1.18
PB Ratio0.89
Price to Fair Value0.89
Price to FCF16.23
Price to Operating Cash Flow4.52
PEG Ratio1.82
Income Statement
In the last 12 months, Essex Bio-Technology had revenue of 1.81B and earned 318.09M in profits. Earnings per share was 0.56.
Revenue1.81B
Gross Profit1.62B
Operating Income367.81M
Pretax Income414.66M
Net Income318.09M
EBITDA467.90M
Earnings Per Share (EPS)0.56
Cash Flow
In the last 12 months, operating cash flow was 284.95M and capital expenditures -131.32M, giving a free cash flow of 153.63M billion.
Operating Cash Flow284.95M
Free Cash Flow153.63M
Free Cash Flow per Share0.27
Dividends & Yields
Essex Bio-Technology pays an annual dividend of HK$0.05, resulting in a dividend yield of 5.29%
Dividend Per ShareHK$0.05
Dividend Yield5.29%
Payout Ratio24.96%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change-54.23%
50-Day Moving Average2.52
200-Day Moving Average3.34
Relative Strength Index (RSI)38.33
Average Volume (3m)863.25K
Important Dates
Essex Bio-Technology upcoming earnings date is Mar 11, 2027, TBA (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateMar 11, 2027
Ex-Dividend Date―
Financial Position
Essex Bio-Technology as a current ratio of 2.11, with Debt / Equity ratio of 13.69%
Current Ratio2.11
Quick Ratio2.01
Debt to Market Cap0.15
Net Debt to EBITDA-0.93
Interest Coverage Ratio47.06
Taxes
In the past 12 months, Essex Bio-Technology has paid 96.57M in taxes.
Income Tax96.57M
Effective Tax Rate0.23
Enterprise Valuation
Essex Bio-Technology EV to EBITDA ratio is 3.64, with an EV/FCF ratio of 12.92.
EV to Sales0.94
EV to EBITDA3.64
EV to Free Cash Flow12.92
EV to Operating Cash Flow5.56
Balance Sheet
Essex Bio-Technology has HK$807.73M in cash and marketable securities with HK$348.99M in debt, giving a net cash position of HK$458.74M billion.
Cash & Marketable SecuritiesHK$807.73M
Total DebtHK$348.99M
Net CashHK$458.74M
Net Cash Per ShareHK$0.81
Tangible Book Value Per ShareHK$1.92
Margins
Gross margin is 86.85%, with operating margin of 20.28%, and net profit margin of 17.54%.
Gross Margin86.85%
Operating Margin20.28%
Pretax Margin22.86%
Net Profit Margin17.54%
EBITDA Margin25.80%
EBIT Margin22.98%
Analyst Forecast
The average price target for Essex Bio-Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-0.74%
EPS Growth Forecast-15.21%